Walleye Trading LLC Global Blood Therapeutics, Inc. Transaction History

Walleye Trading LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$22.3 - $37.39 $103,984 - $174,349	-4,663 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $33,589 - $46,551	-1,308 Reduced 21.91%	4,663 $162,000
Q3 2021 Nov 15, 2021	SELL	$25.48 - $37.34 $490,540 - $718,869	-19,252 Reduced 76.33%	5,971 $152,000
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $359,721 - $481,180	11,082 Added 78.37%	25,223 $883,000
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $2.49 Million - $3.25 Million	-63,839 Reduced 81.87%	14,141 $576,000
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $2.74 Million - $4.63 Million	72,672 Added 1369.1%	77,980 $3.38 Million
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $280,050 - $395,392	5,308 New	5,308 $293,000
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $20,710 - $34,465	-523 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $15,533 - $23,901	523	523 $21,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.